Printer Friendly

MSA enters joint agreement with Mayo Clinic for blood and marrow transplant software.

Management Science Associates, Inc., (MSA), Pittsburgh, PA, announced it has entered into a joint agreement with Mayo Clinic to extend MSA's transplant software EDIT (Electronic Data Interface for Transplantation), beyond solid organ transplantation to include a Blood and Marrow Transplantation (BMT) module. Additional efforts will focus on advancements in clinical usability for even greater clarity and speed in the execution of the transplant workflow process.

With the rapid evolution of solid organ, blood and marrow, and cell transplantation, the need for a premium integrated application and database is paramount, MSA said in a press release. This is particularly the case when tracking and impacting outcomes for patients that receive both solid and non-solid transplantations. Clinical characteristics including demographics, disorders, source of organ or tissue immunosuppressive drug regimens to defend against GVHD and graft rejection are some of the focus areas of this joint development effort. Equally relevant will be the ability of the application to work across clinical disciplines and with outside parties, including relevant information transfer between cell therapy and interfacing with the UNOS and CIBMTR registries.

MSA said its EDIT software was designed as a tool specifically for transplant departments and clinics. EDIT is a full-featured, clinical, data-management solution for the unique requirements of a transplant center. EDIT tracks patients through post-transplant follow-up by seamlessly interfacing with internal and external data sources and clinical registries to create a comprehensive view focused on transplantation. The company said the comprehensive review is critical for patient care and required for research activities.

MSA also has offices in New York; Atlanta; High Point, NC; Las Vegas; Cardiff, UK; Shanghai, China and Kuala Lumpur, Malaysia. Go to:
COPYRIGHT 2013 Transplant Communications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Business Briefs
Publication:Transplant News
Date:Apr 1, 2013
Previous Article:Pain killers could prove helpful in stem-cell transplants.
Next Article:CryoLife gets FDA clearance for next generation HeRO Device.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters